GL1X · GenesisL1 explorer

MolNFT v1 · #176962 · protein

Crystal structure of the SARS-cov-2 papain-like protease (plpro) C112S mutant bound to compound S43

7E35 · Non-structural protein 3: “Crystal structure of the SARS-cov-2 papain-like protease (plpro) C112S mutant bound to compound S43”. X-ray diffraction, 2 ligands (GYX, ZN), 6 pockets (best druggability 0.89). MolNFT v1 #176962 on…

PDB
7E35
Type
protein
Length
602 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1
Ligands
GYX, ZN
Pockets
6 · best druggability 0.89

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BNon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein28727% helix, 31% strandP0DTD1
ANon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein31527% helix, 35% strandP0DTD1

Ligands and binding sites

  • GYX · N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide · ligand · 2 copies · chains B, A
  • ZN · Zinc ion · metal · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110220.890.91136GYX
2630.720.9718empty
31210.470.7821empty
4690.430.8013empty
5610.390.8011empty

Interfaces

1 interface between chains.

  • B–A · 1306 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 7E35 · Crystal structure of the SARS-CoV-2 papain-like protease (PLPro) C112S mutant bound to… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.